{
    "2020-07-01": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novartis pays $729 million to settle U.S. kickback charges",
                "features": {
                    "keywords": [
                        "Novartis",
                        "settle",
                        "kickback",
                        "charges"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Amgen's Win, Netflix's Hire Send Nasdaq Higher",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Netflix",
                        "Nasdaq",
                        "Higher"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "entertainment",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise",
                "features": {
                    "keywords": [
                        "Amgen",
                        "patents",
                        "Enbrel",
                        "upheld",
                        "shares",
                        "rise"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}